Home>Topics>Stocks>Trinity Biotech PLC ADR

Trinity Biotech PLC ADR

  1. All
  2. Commentary
  3. Headlines
  1. Trinity Bio to report on October 23

    Headlines

    Mon, 6 Oct 2014

    Trinity Biotech ( TRIB -2.3% ) will report Q3 results on October 23. The conference call will begin at 11:00 am ET. Consensus view is EPS of $0.20 on revenues of $27.3M. Post your comment!

  2. 10 Healthcare Dogs: 12% To 35% September Upsides, 1 Runt Hits 75%

    Headlines

    Sat, 27 Sep 2014

    showed Trinity Biotech Plc (NASDAQ: TRIB ), flaunted a 75.09% price upside to lead the healthcare sector. However, the TRIB dog did not even throw enough dividend ..... 3% to 34.53% Upsides; Low Yielder TRIB Was Slated to Hit 75% The charts above

  3. From Barron’s, April 28, 2014 (Part 2)

    Commentary

    Sat, 26 Apr 2014

    buying AZN ; pg 19]; Tullow Oil [TLW.uk; pg 20]; Irish small-cap medical testing equipment maker Trinity Biotech [ TRIB ; pg 40]. AIG story http://online.barrons.com/news/articles/SB50001424053111903409104579515680983549344?mod

  4. From Barron’s, July 22, 2013 (Part 2)

    Commentary

    Sat, 20 Jul 2013

    150; pg 20]; global energy producer Hess [ HES ; pg 22]; medical testing equipment/instrument maker Trinity Biotech [ TRIB ; for diabetes at $25,000/device, Lyme disease, autoimmune disorders, herpes, syphilis, strep pneumonia, cardiac evaluation

  5. From Barron’s, October 1, 2012 (Part 2)

    Commentary

    Sat, 29 Sep 2012

    spinoff from Kraft ( KFT ) whose new ticker will be KRFT ; pg 16); diabetes and other testing equipment maker Trinity Biotech ( TRIB ; pg 19); Steelcase ( SCS ; pg 20; see link below). SCS story http://online.barrons.com/article/SB50001424053111904414004578016383267957450

Content Partners